|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q42482144
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010713.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q42482144
|
|
024
|
|
|
‡a
0000-0002-4603-9504
‡2
orcid
|
|
024
|
|
|
‡a
7403194727
‡2
scopus
|
|
024
|
|
|
‡a
57169495200
‡2
scopus
|
|
024
|
|
|
‡a
57031213400
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q42482144
|
|
100
|
0 |
|
‡a
Marianne Andersen
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Marianne Andersen
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Marianne Andersen
‡c
investigadora
‡9
es
|
|
670
|
|
|
‡a
Author's A 12-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acr Omega ly
|
|
670
|
|
|
‡a
Author's A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes
|
|
670
|
|
|
‡a
Author's A common LRP4 haplotype is associated with bone mineral density and hip geometry in men-data from the Odense Androgen Study (OAS).
|
|
670
|
|
|
‡a
Author's A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's A rare cause of Cushing's syndrome: an ACTH-secreting phaeochromocytoma
|
|
670
|
|
|
‡a
Author's Acr Omega ly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
|
|
670
|
|
|
‡a
Author's [Acr Omega ly: new principles for treatment]
|
|
670
|
|
|
‡a
Author's Acute presentation of craniopharyngioma in children and adults in a Danish national cohort
|
|
670
|
|
|
‡a
Author's Adiponectin and Peak Bone Mass in Men: A Cross-Sectional, Population-Based Study
|
|
670
|
|
|
‡a
Author's Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS.
|
|
670
|
|
|
‡a
Author's Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome.
|
|
670
|
|
|
‡a
Author's Aldosterone, Salt, and Potassium Intakes as Predictors of Pregnancy Outcome, Including Preeclampsia
|
|
670
|
|
|
‡a
Author's An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Anogenital distance as a phenotypic signature through infancy
|
|
670
|
|
|
‡a
Author's Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort
|
|
670
|
|
|
‡a
Author's Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines
|
|
670
|
|
|
‡a
Author's Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial
|
|
670
|
|
|
‡a
Author's Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis
|
|
670
|
|
|
‡a
Author's Association study of common variants in the sFRP1 gene region and parameters of bone strength and body composition in two independent healthy Caucasian male cohorts
|
|
670
|
|
|
‡a
Author's Association study of polymorphisms in the SOST gene region and parameters of bone strength and body composition in both young and elderly men: data from the Odense Androgen Study
|
|
670
|
|
|
‡a
Author's Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe
|
|
670
|
|
|
‡a
Author's Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973-1991.
|
|
670
|
|
|
‡a
Author's Blood Pressure and Angiogenic Markers in Pregnancy: Contributors to Pregnancy-Induced Hypertension and Offspring Cardiovascular Risk
|
|
670
|
|
|
‡a
Author's Blood pressure and hypertension during pregnancy in women with polycystic ovary syndrome. Odense Child Cohort
|
|
670
|
|
|
‡a
Author's Body Composition Is Improved During 12 Months' Treatment With Metformin Alone or Combined With Oral Contraceptives Compared With Treatment With Oral Contraceptives in Polycystic Ovary Syndrome
|
|
670
|
|
|
‡a
Author's Bone mineral density and vitamin D in PCOS and hirsutism
|
|
670
|
|
|
‡a
Author's Brain-derived neurotrophic factor (BDNF) serum basal levels is not affected by power training in mobility-limited older adults - A randomized controlled trial
|
|
670
|
|
|
‡a
Author's Cancer Incidence in Patients with Acr Omega ly: A cohort study and meta-analysis of the literature.
|
|
670
|
|
|
‡a
Author's Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
|
|
670
|
|
|
‡a
Author's Chronic diseases in elderly men: underreporting and underdiagnosis
|
|
670
|
|
|
‡a
Author's Clinical manifest x-linked recessive adrenoleukodystrophy in a female
|
|
670
|
|
|
‡a
Author's Club foot
|
|
670
|
|
|
‡a
Author's Common Genetic Variation in the DKK1 Gene is Associated with Hip Axis Length but not with Bone Mineral Density and Bone Turnover Markers in Young Adult Men: Results from the Odense Androgen Study
|
|
670
|
|
|
‡a
Author's Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
|
|
670
|
|
|
‡a
Author's Corrigendum. Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort
|
|
670
|
|
|
‡a
Author's Corticotroph aggressive pituitary tumours and carcinomas frequently harbour ATRX mutations
|
|
670
|
|
|
‡a
Author's Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status
|
|
670
|
|
|
‡a
Author's Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters
|
|
670
|
|
|
‡a
Author's Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
|
|
670
|
|
|
‡a
Author's Development of acr Omega ly in patients with prolactinomas.
|
|
670
|
|
|
‡a
Author's Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?
|
|
670
|
|
|
‡a
Author's Diagnosis of Growth Hormone Deficiency
|
|
670
|
|
|
‡a
Author's Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women
|
|
670
|
|
|
‡a
Author's Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
|
|
670
|
|
|
‡a
Author's Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
|
|
670
|
|
|
‡a
Author's Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency
|
|
670
|
|
|
‡a
Author's Early pregnancy vitamin D status is associated with blood pressure in children: an Odense Child Cohort study
|
|
670
|
|
|
‡a
Author's Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acr Omega lic patients. A double blind placebo-controlled cross-over study
|
|
670
|
|
|
‡a
Author's Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
|
|
670
|
|
|
‡a
Author's Effect of testosterone on markers of mitochondrial oxidative phosphorylation and lipid metabolism in muscle of aging men with subnormal bioavailable testosterone.
|
|
670
|
|
|
‡a
Author's Effectiveness of One-Way Text Messaging on Attendance to Follow-Up Cervical Cancer Screening Among Human Papillomavirus-Positive Tanzanian Women (Connected2Care): Parallel-Group Randomized Controlled Trial
|
|
670
|
|
|
‡a
Author's Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.
|
|
670
|
|
|
‡a
Author's [Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome]
|
|
670
|
|
|
‡a
Author's Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark.
|
|
670
|
|
|
‡a
Author's Evaluation of growth hormone assays using ratio plots
|
|
670
|
|
|
‡a
Author's Evaluation of growth hormone stimulation tests in cured acr Omega lic patients
|
|
670
|
|
|
‡a
Author's Evaluation of ICD-10 algorithms to identify hypopituitary patients in the Danish National Patient Registry
|
|
670
|
|
|
‡a
Author's Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls
|
|
670
|
|
|
‡a
Author's Evaluation of the optimum dose of growth hormone
|
|
670
|
|
|
‡a
Author's Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies.
|
|
670
|
|
|
‡a
Author's Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort
|
|
670
|
|
|
‡a
Author's Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents
|
|
670
|
|
|
‡a
Author's Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels
|
|
670
|
|
|
‡a
Author's Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort Study
|
|
670
|
|
|
‡a
Author's Fracture risk is increased in patients with GH deficiency or untreated prolactinomas - a case-control study
|
|
670
|
|
|
‡a
Author's Gene expression profiling of fast- and slow- growing gonadotroph non-functioning pituitary adenomas
|
|
670
|
|
|
‡a
Author's Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS)
|
|
670
|
|
|
‡a
Author's Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Belgian males
|
|
670
|
|
|
‡a
Author's Genetic Screening of WNT4 and WNT5B in Two Populations with Deviating Bone Mineral Densities
|
|
670
|
|
|
‡a
Author's Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis
|
|
670
|
|
|
‡a
Author's Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study
|
|
670
|
|
|
‡a
Author's Gestational Diabetes Mellitus: Does One Size Fit All? A Challenge to Uniform Worldwide Diagnostic Thresholds
|
|
670
|
|
|
‡a
Author's Giant prolactinomas in women
|
|
670
|
|
|
‡a
Author's Graphical interpretation of confidence curves in rankit plots
|
|
670
|
|
|
‡a
Author's Hair cortisol in the perinatal period mediates associations between maternal adversity and disrupted maternal interaction in early infancy
|
|
670
|
|
|
‡a
Author's Health anxiety symptoms in Danish children during the first lockdown period of the COVID-19 pandemic: an Odense Child Cohort study
|
|
670
|
|
|
‡a
Author's Heart valve disease among patients with hyperprolactinemia: a nationwide population-based cohort study
|
|
670
|
|
|
‡a
Author's Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome.
|
|
670
|
|
|
‡a
Author's Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism
|
|
670
|
|
|
‡a
Author's Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes
|
|
670
|
|
|
‡a
Author's Impaired Respiratory Function in Women With PCOS Compared With Matched Controls From a Population-Based Study
|
|
670
|
|
|
‡a
Author's In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas
|
|
670
|
|
|
‡a
Author's Incidence of craniopharyngioma in Denmark
|
|
670
|
|
|
‡a
Author's Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults
|
|
670
|
|
|
‡a
Author's Incidence of GH deficiency - a nationwide study
|
|
670
|
|
|
‡a
Author's Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
|
|
670
|
|
|
‡a
Author's Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
|
|
670
|
|
|
‡a
Author's Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa
|
|
670
|
|
|
‡a
Author's Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and 3 years of age.
|
|
670
|
|
|
‡a
Author's Intraoperative low field MRI in transsphenoidal pituitary surgery
|
|
670
|
|
|
‡a
Author's Is glycyrrhizin sensitivity increased in anorexia nervosa and should licorice be avoided? Case report and review of the literature
|
|
670
|
|
|
‡a
Author's Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males
|
|
670
|
|
|
‡a
Author's Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
|
|
670
|
|
|
‡a
Author's Licorice-induced apparent mineralocorticoid excess compounded by excessive use of terbutaline and high water intake
|
|
670
|
|
|
‡a
Author's Lifestyle Intervention in Danish Obese Pregnant Women With Early Gestational Diabetes Mellitus According to WHO 2013 Criteria Does Not Change Pregnancy Outcomes: Results From the LiP
|
|
670
|
|
|
‡a
Author's Lifestyle Intervention in Danish Obese Pregnant Women With Early Gestational Diabetes Mellitus According to WHO 2013 Criteria Does Not Change Pregnancy Outcomes: Results From the LiP (Lifestyle in Pregnancy) Study
|
|
670
|
|
|
‡a
Author's Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
|
|
670
|
|
|
‡a
Author's Management of endocrine disease: GH excess: diagnosis and medical therapy
|
|
670
|
|
|
‡a
Author's MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Masculinising testosterone treatment and effects on preclinical cardiovascular disease, muscle strength and power, aggression, physical fitness and respiratory function in transgender men: protocol for a 10-year, prospective, observational cohort st
|
|
670
|
|
|
‡a
Author's Maternal prenatal stress and postnatal depressive symptoms: discrepancy between mother and teacher reports of toddler psychological problems
|
|
670
|
|
|
‡a
Author's Maternal Testosterone Concentrations in Third Trimester and Offspring Handgrip Strength at 5 Years: Odense Child Cohort
|
|
670
|
|
|
‡a
Author's Maternal use of mild analgesics during pregnancy associated with reduced anogenital distance in sons: a cohort study of 1027 mother-child pairs
|
|
670
|
|
|
‡a
Author's Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low-normal testosterone levels
|
|
670
|
|
|
‡a
Author's Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review
|
|
670
|
|
|
‡a
Author's Metabolic Syndrome in Hyperprolactinemia
|
|
670
|
|
|
‡a
Author's Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy
|
|
670
|
|
|
‡a
Author's Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial
|
|
670
|
|
|
‡a
Author's Morbidity and GH deficiency: a nationwide study
|
|
670
|
|
|
‡a
Author's Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Morphometric X-ray absorptiometry: reference data for vertebral dimensions in a population-based sample of young Danish men.
|
|
670
|
|
|
‡a
Author's Mortality and GH deficiency: a nationwide study
|
|
670
|
|
|
‡a
Author's Motivational interviewing in obese women with polycystic ovary syndrome - a pilot study
|
|
670
|
|
|
‡a
Author's MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial
|
|
670
|
|
|
‡a
Author's MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study
|
|
670
|
|
|
‡a
Author's Normal range urine albumin excretion associates with blood pressure and renal electrolyte handling in pregnancy
|
|
670
|
|
|
‡a
Author's Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life
|
|
670
|
|
|
‡a
Author's One-way SMS and healthcare outcomes in Africa: Systematic review of randomised trials with meta-analysis
|
|
670
|
|
|
‡a
Author's Osteoporosis and vertebral fractures in men aged 60–74 years
|
|
670
|
|
|
‡a
Author's Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat.
|
|
670
|
|
|
‡a
Author's Patient reported outcome in posttraumatic pituitary deficiency: results from The Danish National Study on posttraumatic hypopituitarism
|
|
670
|
|
|
‡a
Author's Peak muscle mass in young men and sarcopenia in the ageing male
|
|
670
|
|
|
‡a
Author's Pegylated Long-Acting Human Growth Hormone Possesses a Promising Once-Weekly Treatment Profile, and Multiple Dosing Is Well Tolerated in Adult Patients with Growth Hormone Deficiency
|
|
670
|
|
|
‡a
Author's Perfluoroalkyl substances and glycemic status in pregnant Danish women: The Odense Child Cohort.
|
|
670
|
|
|
‡a
Author's Pioglitazone treatment increases spontaneous growth hormone
|
|
670
|
|
|
‡a
Author's Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 Alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
|
|
670
|
|
|
‡a
Author's Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.
|
|
670
|
|
|
‡a
Author's Polycystic ovary syndrome and hyperglycaemia in pregnancy. A narrative review and results from a prospective Danish cohort study
|
|
670
|
|
|
‡a
Author's Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution
|
|
670
|
|
|
‡a
Author's Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense androgen study.
|
|
670
|
|
|
‡a
Author's Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians.
|
|
670
|
|
|
‡a
Author's Population-based reference values for bone mineral density in young men
|
|
670
|
|
|
‡a
Author's Positive associations between serum levels of IGF-I and subcutaneous fat depots in young men. The Odense Androgen Study
|
|
670
|
|
|
‡a
Author's Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
|
|
670
|
|
|
‡a
Author's Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study
|
|
670
|
|
|
‡a
Author's Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
|
|
670
|
|
|
‡a
Author's Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis
|
|
670
|
|
|
‡a
Author's Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense Androgen Study
|
|
670
|
|
|
‡a
Author's Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism
|
|
670
|
|
|
‡a
Author's Prolactin and breast increase during pregnancy in PCOS: linked to long-term metabolic health?
|
|
670
|
|
|
‡a
Author's Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Pulsatile luteinizing hormone secretion in patients with Addison's disease. Impact of glucocorticoid substitution.
|
|
670
|
|
|
‡a
Author's Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy
|
|
670
|
|
|
‡a
Author's Radiographic absorptiometry as a screening tool in male osteoporosis: results from the odense androgen study
|
|
670
|
|
|
‡a
Author's Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial
|
|
670
|
|
|
‡a
Author's Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study
|
|
670
|
|
|
‡a
Author's Response to Letter to the Editor: "Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome".
|
|
670
|
|
|
‡a
Author's Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency
|
|
670
|
|
|
‡a
Author's Risk of impaired glucose tolerance in normal weight hirsute women during four years observation
|
|
670
|
|
|
‡a
Author's Should we individualize lipid profiling in women with polycystic ovary syndrome?
|
|
670
|
|
|
‡a
Author's Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls
|
|
670
|
|
|
‡a
Author's Similar reference intervals for total testosterone in healthy young and elderly men: results from the Odense Androgen Study
|
|
670
|
|
|
‡a
Author's Single nucleotide polymorphisms in sFRP4 are associated with bone and body composition related parameters in Danish but not in Belgian men.
|
|
670
|
|
|
‡a
Author's Slow-growing craniopharyngioma masquarading as early-onset eating disorder: two cases
|
|
670
|
|
|
‡a
Author's Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome.
|
|
670
|
|
|
‡a
Author's Socioeconomic status in Danish women with polycystic ovary syndrome: A register-based cohort study
|
|
670
|
|
|
‡a
Author's Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
|
|
670
|
|
|
‡a
Author's Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men.
|
|
670
|
|
|
‡a
Author's Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.
|
|
670
|
|
|
‡a
Author's Supportive relationships – Psychological effects of group counselling in women with polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Supportive relationships – Psychological effects of group counselling in women with polycystic ovary syndrome (PCOS)
|
|
670
|
|
|
‡a
Author's Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study
|
|
670
|
|
|
‡a
Author's Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans.
|
|
670
|
|
|
‡a
Author's Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma
|
|
670
|
|
|
‡a
Author's Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acr Omega ly: a randomized multicentre study
|
|
670
|
|
|
‡a
Author's Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
|
|
670
|
|
|
‡a
Author's Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort
|
|
670
|
|
|
‡a
Author's Testosterone therapy decreases subcutaneous fat and adiponectin in aging men
|
|
670
|
|
|
‡a
Author's Testosterone therapy increased muscle mass and lipid oxidation in aging men.
|
|
670
|
|
|
‡a
Author's Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
|
|
670
|
|
|
‡a
Author's Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women
|
|
670
|
|
|
‡a
Author's Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women (Connected2Care): study protocol for a randomised controlled trial
|
|
670
|
|
|
‡a
Author's The activity of satellite cells and myonuclei following 8 weeks of strength training in young men with suppressed testosterone levels
|
|
670
|
|
|
‡a
Author's The Diagnosis of Growth Hormone Deficiency in Adults1
|
|
670
|
|
|
‡a
Author's The effect of short-term cortisol changes on growth hormone responses to the pyridostigmine-growth-hormone-releasing-hormone test in healthy adults and patients with suspected growth hormone deficiency
|
|
670
|
|
|
‡a
Author's The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acr Omega ly
|
|
670
|
|
|
‡a
Author's The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study
|
|
670
|
|
|
‡a
Author's [The Odense Androgen Study]
|
|
670
|
|
|
‡a
Author's The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
|
|
670
|
|
|
‡a
Author's The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism
|
|
670
|
|
|
‡a
Author's The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.
|
|
670
|
|
|
‡a
Author's The relationship between health-related quality of life, obesity and testosterone levels in older men.
|
|
670
|
|
|
‡a
Author's The robustness of diagnostic tests for GH deficiency in adults
|
|
670
|
|
|
‡a
Author's The role of lanreotide Autogel®in the treatment of acr Omega ly
|
|
670
|
|
|
‡a
Author's Thiazolinedione treatment in PCOS--an update
|
|
670
|
|
|
‡a
Author's Third trimester cortisol status is associated with offspring sex and polycystic ovary syndrome status: Odense Child Cohort
|
|
670
|
|
|
‡a
Author's Total and high molecular weight
|
|
670
|
|
|
‡a
Author's Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide
|
|
670
|
|
|
‡a
Author's Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters
|
|
670
|
|
|
‡a
Author's Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism
|
|
670
|
|
|
‡a
Author's Visceral and Subcutaneous Adipose Tissue Assessed by Magnetic Resonance Imaging in Relation to Circulating Androgens, Sex Hormone-Binding Globulin, and Luteinizing Hormone in Young Men
|
|
670
|
|
|
‡a
Author's Vitamin D levels were significantly higher during and after lifestyle intervention in pregnancy: A randomized controlled trial
|
|
670
|
|
|
‡a
Author's Vitamin D status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism
|
|
670
|
|
|
‡a
Author's Voluntary muscle activation improves with power training and is associated with changes in gait speed in mobility-limited older adults - A randomized controlled trial
|
|
670
|
|
|
‡a
Author's Wellbeing and resilience: mechanisms of transmission of health and risk in parents with complex mental health problems and their offspring--The WARM Study
|
|
909
|
|
|
‡a
(scopus) 57031213400
‡9
1
|
|
909
|
|
|
‡a
(scopus) 57169495200
‡9
1
|
|
909
|
|
|
‡a
(scopus) 7403194727
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000246039504
‡9
1
|
|
919
|
|
|
‡a
variationinthekozaksequenceofwnt16resultsinanincreasedtranslationandisassociatedwithosteoporosisrelatedparameters
‡A
Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters
‡9
1
|
|
919
|
|
|
‡a
tumoralmgmtcontentpredictssurvivalinpatientswithaggressivepituitarytumorsandpituitarycarcinomasgiventreatmentwithtemozolomide
‡A
Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide
‡9
1
|
|
919
|
|
|
‡a
totalandhighmolecularweighthmwadiponectinlevelsandmeasuresofglucoseandlipidmetabolismfollowingpioglitazonetreatmentinarandomizedplacebocontrolledstudyinpolycysticovarysyndrome
‡A
Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
totalandhighmolecularweight
‡A
Total and high molecular weight
‡9
1
|
|
919
|
|
|
‡a
3trimestercortisolstatusisassociatedwithoffspringsexandpolycysticovarysyndromestatusodensechildcohort
‡A
Third trimester cortisol status is associated with offspring sex and polycystic ovary syndrome status: Odense Child Cohort
‡9
1
|
|
919
|
|
|
‡a
thiazolinedionetreatmentinpcosanupdate
‡A
Thiazolinedione treatment in PCOS--an update
‡9
1
|
|
919
|
|
|
‡a
roleoflanreotideautogelinthetreatmentofacr Omega ly
‡A
The role of lanreotide Autogel®in the treatment of acr Omega ly
‡9
1
|
|
919
|
|
|
‡a
robustnessofdiagnostictestsforghdeficiencyinadults
‡A
The robustness of diagnostic tests for GH deficiency in adults
‡9
1
|
|
919
|
|
|
‡a
relationshipbetweenhealthrelatedqualityoflifeobesityandtestosteronelevelsinoldermen
‡A
The relationship between health-related quality of life, obesity and testosterone levels in older men.
‡9
1
|
|
919
|
|
|
‡a
prevalenceoftype2diabetesisnotincreasedinnormalweightwomenwithpcos
‡A
The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.
‡9
1
|
|
919
|
|
|
‡a
prevalenceofendometrialhyperplasiaandendometrialcancerinwomenwithpolycysticovarysyndromeorhyperandrogenism
‡A
The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism
‡9
1
|
|
919
|
|
|
‡a
pharmacogeneticsofmetformininwomenwithpolycysticovarysyndromearandomizedtrial
‡A
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
‡9
1
|
|
919
|
|
|
‡a
odenseandrogenstudy
‡A
[The Odense Androgen Study]
‡9
1
|
|
919
|
|
|
‡a
impactofthecagrepeatpolymorphismoftheandrogenreceptorgeneonmuscleandadiposetissuesin2029yearolddanishmenodenseandrogenstudy
‡A
The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study
‡9
1
|
|
919
|
|
|
‡a
impactofpegvisomanttreatmentonsubstratemetabolismandinsulinsensitivityinpatientswithacr Omega ly
‡A
The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acr Omega ly
‡9
1
|
|
919
|
|
|
‡a
effectofshorttermcortisolchangesongrowthhormoneresponsestothepyridostigminegrowthhormonereleasinghormonetestinhealthyadultsandpatientswithsuspectedgrowthhormonedeficiency
‡A
The effect of short-term cortisol changes on growth hormone responses to the pyridostigmine-growth-hormone-releasing-hormone test in healthy adults and patients with suspected growth hormone deficiency
‡9
1
|
|
919
|
|
|
‡a
diagnosisofgrowthhormonedeficiencyinadults1
‡A
The Diagnosis of Growth Hormone Deficiency in Adults1
‡9
1
|
|
919
|
|
|
‡a
activityofsatellitecellsandmyonucleifollowing8weeksofstrengthtraininginyoungmenwithsuppressedtestosteronelevels
‡A
The activity of satellite cells and myonuclei following 8 weeks of strength training in young men with suppressed testosterone levels
‡9
1
|
|
919
|
|
|
‡a
textmessagestoincreaseattendancetofollowupcervicalcancerscreeningappointmentsamonghpvpositivetanzanianwomenconnected2carestudyprotocolforarandomisedcontrolledtrial
‡A
Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women (Connected2Care): study protocol for a randomised controlled trial
‡9
1
|
|
919
|
|
|
‡a
textmessagestoincreaseattendancetofollowupcervicalcancerscreeningappointmentsamonghpvpositivetanzanianwomen
‡A
Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women
‡9
1
|
|
919
|
|
|
‡a
testosteronetherapypreservesmusclestrengthandpowerinagingmenwithtype2diabetesarandomizedcontrolledtrial
‡A
Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
‡9
1
|
|
919
|
|
|
‡a
testosteronetherapyincreasedmusclemassandlipidoxidationinagingmen
‡A
Testosterone therapy increased muscle mass and lipid oxidation in aging men.
‡9
1
|
|
919
|
|
|
‡a
testosteronetherapydecreasessubcutaneousfatandadiponectininagingmen
‡A
Testosterone therapy decreases subcutaneous fat and adiponectin in aging men
‡9
1
|
|
919
|
|
|
‡a
testosteronelevelsin3trimesterinpolycysticovarysyndromeodensechildcohort
‡A
Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort
‡9
1
|
|
919
|
|
|
‡a
temozolomidetreatmentofapituitarycarcinomaand2pituitarymacroadenomasresistanttoconventionaltherapy
‡A
Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
‡9
1
|
|
919
|
|
|
‡a
targetingeitherghorigf1duringsomatostatinanaloguetreatmentinpatientswithacr Omega lyarandomizedmulticentrestudy
‡A
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acr Omega ly: a randomized multicentre study
‡9
1
|
|
919
|
|
|
‡a
systematicgeneticscreeninginaprospectivegroupofdanishpatientswithpheochromocytoma
‡A
Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma
‡9
1
|
|
919
|
|
|
‡a
suppressionoftestosteronedoesnotbluntmrnaexpressionofmyodmyogeninigfmyostatinorandrogenreceptorpoststrengthtraininginhumans
‡A
Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans.
‡9
1
|
|
919
|
|
|
‡a
suppressionofendogenoustestosteroneproductionattenuatestheresponsetostrengthtrainingarandomizedplacebocontrolledandblindedinterventionstudy
‡A
Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study
‡9
1
|
|
919
|
|
|
‡a
supportiverelationshipspsychologicaleffectsofgroupcounsellinginwomenwithpolycysticovarysyndromepcos
‡A
Supportive relationships – Psychological effects of group counselling in women with polycystic ovary syndrome (PCOS)
‡9
1
|
|
919
|
|
|
‡a
supportiverelationshipspsychologicaleffectsofgroupcounsellinginwomenwithpolycysticovarysyndrome
‡A
Supportive relationships – Psychological effects of group counselling in women with polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
subcutaneousratherthanvisceraladiposetissueisassociatedwithadiponectinlevelsandinsulinresistanceinyoungmen
‡A
Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.
‡9
1
|
|
919
|
|
|
‡a
strengthtrainingandtestosteronetreatmenthaveopposingeffectsonmigrationinhibitorfactorlevelsinageingmen
‡A
Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men.
‡9
1
|
|
919
|
|
|
‡a
solublecd36andriskmarkersofinsulinresistanceandatherosclerosisareelevatedinpolycysticovarysyndromeandsignificantlyreducedduringpioglitazonetreatment
‡A
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
‡9
1
|
|
919
|
|
|
‡a
socioeconomicstatusindanishwomenwithpolycysticovarysyndromearegisterbasedcohortstudy
‡A
Socioeconomic status in Danish women with polycystic ovary syndrome: A register-based cohort study
‡9
1
|
|
919
|
|
|
‡a
smokingisassociatedwithincreasedadrenalresponsivenessdecreasedprolactinlevelsandamoreadverselipidprofilein650whitepatientswithpolycysticovarysyndrome
‡A
Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome.
‡9
1
|
|
919
|
|
|
‡a
slowgrowingcraniopharyngiomamasquaradingasearlyonseteatingdisorder2cases
‡A
Slow-growing craniopharyngioma masquarading as early-onset eating disorder: two cases
‡9
1
|
|
919
|
|
|
‡a
singlenucleotidepolymorphismsinsfrp4areassociatedwithboneandbodycompositionrelatedparametersindanishbutnotinbelgianmen
‡A
Single nucleotide polymorphisms in sFRP4 are associated with bone and body composition related parameters in Danish but not in Belgian men.
‡9
1
|
|
919
|
|
|
‡a
similarreferenceintervalsfortotaltestosteroneinhealthyyoungandelderlymenresultsfromtheodenseandrogenstudy
‡A
Similar reference intervals for total testosterone in healthy young and elderly men: results from the Odense Androgen Study
‡9
1
|
|
919
|
|
|
‡a
significantlyhigheradrenocorticotropinstimulatedcortisoland17hydroxyprogesteronelevelsin337consecutivepremenopausalcaucasianhirsutepatientscomparedwithhealthycontrols
‡A
Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls
‡9
1
|
|
919
|
|
|
‡a
shouldweindividualizelipidprofilinginwomenwithpolycysticovarysyndrome
‡A
Should we individualize lipid profiling in women with polycystic ovary syndrome?
‡9
1
|
|
919
|
|
|
‡a
riskofimpairedglucosetoleranceinnormalweighthirsutewomenduring4yearsobservation
‡A
Risk of impaired glucose tolerance in normal weight hirsute women during four years observation
‡9
1
|
|
919
|
|
|
‡a
reversiblealbuminbindingghpossessesapotential11weeklytreatmentprofileinadultgrowthhormonedeficiency
‡A
Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency
‡9
1
|
|
919
|
|
|
‡a
responsetolettertotheeditordevelopmentandriskfactorsoftype2diabetesinanationwidepopulationofwomenwithpolycysticovarysyndrome
‡A
Response to Letter to the Editor: "Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome".
‡9
1
|
|
919
|
|
|
‡a
resistinpolymorphismsshowassociationswithobesitybutnotwithboneparametersinmenresultsfromtheodenseandrogenstudy
‡A
Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study
‡9
1
|
|
919
|
|
|
‡a
reductionofcalprotectinandphosphateduringtestosteronetherapyinagingmenarandomizedcontrolledtrial
‡A
Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial
‡9
1
|
|
919
|
|
|
‡a
radiographicabsorptiometryasascreeningtoolinmaleosteoporosisresultsfromtheodenseandrogenstudy
‡A
Radiographic absorptiometry as a screening tool in male osteoporosis: results from the odense androgen study
‡9
1
|
|
919
|
|
|
‡a
pulsatilethyrotropinsecretioninpatientswithaddisonsdiseaseduringvariableglucocorticoidtherapy
‡A
Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy
‡9
1
|
|
919
|
|
|
‡a
pulsatileluteinizinghormonesecretioninpatientswithaddisonsdiseaseimpactofglucocorticoidsubstitution
‡A
Pulsatile luteinizing hormone secretion in patients with Addison's disease. Impact of glucocorticoid substitution.
‡9
1
|
|
919
|
|
|
‡a
prolactinisassociatedwithmetabolicriskandcortisolin1007womenwithpolycysticovarysyndrome
‡A
Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
prolactinandbreastincreaseduringpregnancyinpcoslinkedtolongtermmetabolichealth
‡A
Prolactin and breast increase during pregnancy in PCOS: linked to long-term metabolic health?
‡9
1
|
|
919
|
|
|
‡a
prevalenceofposttraumaticgrowthhormonedeficiencyishighlydependentonthediagnosticsetupresultsfromthedanishnationalstudyonposttraumatichypopituitarism
‡A
Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism
‡9
1
|
|
919
|
|
|
‡a
prevalenceofoverweightobesityandphysicalinactivityin20to29yearolddanishmenrelationtosociodemographyphysicaldysfunctionandlowsocioeconomicstatustheodenseandrogenstudy
‡A
Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense Androgen Study
‡9
1
|
|
919
|
|
|
‡a
prevalenceofendocrinediseasesandabnormalglucosetolerancetestsin340caucasianpremenopausalwomenwithhirsutismasthereferraldiagnosis
‡A
Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis
‡9
1
|
|
919
|
|
|
‡a
prevalenceandpossiblemechanismsofreactivehypoglycemiainpolycysticovarysyndrome
‡A
Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
‡9
1
|
|
919
|
|
|
‡a
prescriptionofantidepressantsisincreasedindanishpatientswithpolycysticovarysyndromeandisassociatedwithhyperandrogenismapopulationbasedcohortstudy
‡A
Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study
‡9
1
|
|
919
|
|
|
‡a
prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
‡A
Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
‡9
1
|
|
919
|
|
|
‡a
positiveassociationsbetweenserumlevelsofigf1andsubcutaneousfatdepotsinyoungmentheodenseandrogenstudy
‡A
Positive associations between serum levels of IGF-I and subcutaneous fat depots in young men. The Odense Androgen Study
‡9
1
|
|
919
|
|
|
‡a
populationbasedreferencevaluesforbonemineraldensityinyoungmen
‡A
Population-based reference values for bone mineral density in young men
‡9
1
|
|
919
|
|
|
‡a
polymorphismsofmusclegenesareassociatedwithbonemassandincidentosteoporoticfracturesincaucasians
‡A
Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians.
‡9
1
|
|
919
|
|
|
‡a
polymorphismsinthelowdensitylipoproteinreceptorrelatedprotein5lrp5geneareassociatedwithpeakbonemassinnonsedentarymenresultsfromtheodenseandrogenstudy
‡A
Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense androgen study.
‡9
1
|
|
919
|
|
|
‡a
polymorphismsintheendocannabinoidreceptor1inrelationtofatmassdistribution
‡A
Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution
‡9
1
|
|
919
|
|
|
‡a
polycysticovarysyndromeandhyperglycaemiainpregnancyanarrativereviewandresultsfromaprospectivedanishcohortstudy
‡A
Polycystic ovary syndrome and hyperglycaemia in pregnancy. A narrative review and results from a prospective Danish cohort study
‡9
1
|
|
919
|
|
|
‡a
plasmaosteoprotegerinisassociatedwithtestosteronelevelsbutunaffectedbypioglitazonetreatmentinpatientswithpolycysticovarysyndrome
‡A
Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.
‡9
1
|
|
919
|
|
|
‡a
plasmamonocytechemoattractantprotein1mcp1andmacrophageinflammatoryprotein1 Alpha areincreasedinpatientswithpolycysticovarysyndromepcosandassociatedwithadipositybutunaffectedbypioglitazonetreatment
‡A
Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 Alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
‡9
1
|
|
919
|
|
|
‡a
pioglitazonetreatmentincreasesspontaneousgrowthhormoneghsecretionandstimulatedghlevelsinpolycysticovarysyndrome
‡A
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
pioglitazonetreatmentincreasesspontaneousgrowthhormone
‡A
Pioglitazone treatment increases spontaneous growth hormone
‡9
1
|
|
919
|
|
|
‡a
perfluoroalkylsubstancesandglycemicstatusinpregnantdanishwomentheodensechildcohort
‡A
Perfluoroalkyl substances and glycemic status in pregnant Danish women: The Odense Child Cohort.
‡9
1
|
|
919
|
|
|
‡a
pegylatedlongactinghumangrowthhormonepossessesapromising11weeklytreatmentprofileandmultipledosingiswelltoleratedinadultpatientswithgrowthhormonedeficiency
‡A
Pegylated Long-Acting Human Growth Hormone Possesses a Promising Once-Weekly Treatment Profile, and Multiple Dosing Is Well Tolerated in Adult Patients with Growth Hormone Deficiency
‡9
1
|
|
919
|
|
|
‡a
peakmusclemassinyoungmenandsarcopeniaintheageingmale
‡A
Peak muscle mass in young men and sarcopenia in the ageing male
‡9
1
|
|
919
|
|
|
‡a
patientreportedoutcomeinposttraumaticpituitarydeficiencyresultsfromthedanishnationalstudyonposttraumatichypopituitarism
‡A
Patient reported outcome in posttraumatic pituitary deficiency: results from The Danish National Study on posttraumatic hypopituitarism
‡9
1
|
|
919
|
|
|
‡a
osteoprotegerinlevelsdecreaseduringtestosteronetherapyinagingmenandareassociatedwithchangeddistributionofregionalfat
‡A
Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat.
‡9
1
|
|
919
|
|
|
‡a
osteoporosisandvertebralfracturesinmenaged6074years
‡A
Osteoporosis and vertebral fractures in men aged 60–74 years
‡9
1
|
|
919
|
|
|
‡a
1waysmsandhealthcareoutcomesinafricasystematicreviewofrandomisedtrialswithmetaanalysis
‡A
One-way SMS and healthcare outcomes in Africa: Systematic review of randomised trials with meta-analysis
‡9
1
|
|
919
|
|
|
‡a
normoandhyperandrogenicwomenwithpolycysticovarysyndromeexhibitanadversemetabolicprofilethroughlife
‡A
Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life
‡9
1
|
|
919
|
|
|
‡a
normalrangeurinealbuminexcretionassociateswithbloodpressureandrenalelectrolytehandlinginpregnancy
‡A
Normal range urine albumin excretion associates with blood pressure and renal electrolyte handling in pregnancy
‡9
1
|
|
919
|
|
|
‡a
mthfr100677ctpolymorphismasanindependentpredictorofpeakbonemassindanishmenresultsfromtheodenseandrogenstudy
‡A
MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study
‡9
1
|
|
919
|
|
|
‡a
mrspectroscopyofhepaticfatandadiponectinandleptinlevelsduringtestosteronetherapyintype2diabetesarandomizeddoubleblindedplacebocontrolledtrial
‡A
MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial
‡9
1
|
|
919
|
|
|
‡a
motivationalinterviewinginobesewomenwithpolycysticovarysyndromeapilotstudy
‡A
Motivational interviewing in obese women with polycystic ovary syndrome - a pilot study
‡9
1
|
|
919
|
|
|
‡a
mortalityandghdeficiencyanationwidestudy
‡A
Mortality and GH deficiency: a nationwide study
‡9
1
|
|
919
|
|
|
‡a
morphometric10rayabsorptiometryreferencedataforvertebraldimensionsinapopulationbasedsampleofyoungdanishmen
‡A
Morphometric X-ray absorptiometry: reference data for vertebral dimensions in a population-based sample of young Danish men.
‡9
1
|
|
919
|
|
|
‡a
morbidityandmedicineprescriptionsinanationwidedanishpopulationofpatientsdiagnosedwithpolycysticovarysyndrome
‡A
Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
morbidityandghdeficiencyanationwidestudy
‡A
Morbidity and GH deficiency: a nationwide study
‡9
1
|
|
919
|
|
|
‡a
mitochondriaglycogenandlipiddropletsinskeletalmuscleduringtestosteronetreatmentandstrengthtrainingarandomizeddoubleblindedplacebocontrolledtrial
‡A
Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial
‡9
1
|
|
919
|
|
|
‡a
microvesiclescorrelatedwithcomponentsofmetabolicsyndromeinmenwithtype2diabetesmellitusandloweredtestosteronelevelsbutwereunalteredbytestosteronetherapy
‡A
Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy
‡9
1
|
|
919
|
|
|
‡a
metabolicsyndromeinhyperprolactinemia
‡A
Metabolic Syndrome in Hyperprolactinemia
‡9
1
|
|
919
|
|
|
‡a
medicalcomorbidityinpolycysticovarysyndromewithspecialfocusoncardiometabolicautoimmunehepaticandcancerdiseasesanupdatedreview
‡A
Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review
‡9
1
|
|
919
|
|
|
‡a
mechanicalmusclefunctionandleanbodymassduringsupervisedstrengthtrainingandtestosteronetherapyinagingmenwithlownormaltestosteronelevels
‡A
Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low-normal testosterone levels
‡9
1
|
|
919
|
|
|
‡a
maternaluseofmildanalgesicsduringpregnancyassociatedwithreducedanogenitaldistanceinsonsacohortstudyof1027motherchildpairs
‡A
Maternal use of mild analgesics during pregnancy associated with reduced anogenital distance in sons: a cohort study of 1027 mother-child pairs
‡9
1
|
|
919
|
|
|
‡a
maternaltestosteroneconcentrationsin3trimesterandoffspringhandgripstrengthat5yearsodensechildcohort
‡A
Maternal Testosterone Concentrations in Third Trimester and Offspring Handgrip Strength at 5 Years: Odense Child Cohort
‡9
1
|
|
919
|
|
|
‡a
maternalprenatalstressandpostnataldepressivesymptomsdiscrepancybetweenmotherandteacherreportsoftoddlerpsychologicalproblems
‡A
Maternal prenatal stress and postnatal depressive symptoms: discrepancy between mother and teacher reports of toddler psychological problems
‡9
1
|
|
919
|
|
|
‡a
masculinisingtestosteronetreatmentandeffectsonpreclinicalcardiovasculardiseasemusclestrengthandpoweraggressionphysicalfitnessandrespiratoryfunctionintransgendermenprotocolfora10yearprospectiveobservationalcohortst
‡A
Masculinising testosterone treatment and effects on preclinical cardiovascular disease, muscle strength and power, aggression, physical fitness and respiratory function in transgender men: protocol for a 10-year, prospective, observational cohort st
‡9
1
|
|
919
|
|
|
‡a
managementofendocrinediseasemorbidityinpolycysticovarysyndrome
‡A
MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
managementofendocrinediseaseghexcessdiagnosisandmedicaltherapy
‡A
Management of endocrine disease: GH excess: diagnosis and medical therapy
‡9
1
|
|
919
|
|
|
‡a
longtermoutcomeandmgmtasapredictivemarkerin24patientswithatypicalpituitaryadenomasandpituitarycarcinomasgiventreatmentwithtemozolomide
‡A
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
‡9
1
|
|
919
|
|
|
‡a
lifestyleinterventionindanishobesepregnantwomenwithearlygestationaldiabetesmellitusaccordingtowho2013criteriadoesnotchangepregnancyoutcomesresultsfromtheliplifestyleinpregnancystudy
‡A
Lifestyle Intervention in Danish Obese Pregnant Women With Early Gestational Diabetes Mellitus According to WHO 2013 Criteria Does Not Change Pregnancy Outcomes: Results From the LiP (Lifestyle in Pregnancy) Study
‡9
1
|
|
919
|
|
|
‡a
lifestyleinterventionindanishobesepregnantwomenwithearlygestationaldiabetesmellitusaccordingtowho2013criteriadoesnotchangepregnancyoutcomesresultsfromthelip
‡A
Lifestyle Intervention in Danish Obese Pregnant Women With Early Gestational Diabetes Mellitus According to WHO 2013 Criteria Does Not Change Pregnancy Outcomes: Results From the LiP
‡9
1
|
|
919
|
|
|
‡a
licoriceinducedapparentmineralocorticoidexcesscompoundedbyexcessiveuseofterbutalineandhighwaterintake
‡A
Licorice-induced apparent mineralocorticoid excess compounded by excessive use of terbutaline and high water intake
‡9
1
|
|
919
|
|
|
‡a
largescalegenomewidemetaanalysisofpolycysticovarysyndromesuggestssharedgeneticarchitecturefordifferentdiagnosiscriteria
‡A
Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
‡9
1
|
|
919
|
|
|
‡a
lackofeffectofthedopamined1antagonistnnc010687onunstimulatedandstimulatedreleaseofanteriorpituitaryhormonesinmales
‡A
Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males
‡9
1
|
|
919
|
|
|
‡a
isglycyrrhizinsensitivityincreasedinanorexianervosaandshouldlicoricebeavoidedcasereportandreviewoftheliterature
‡A
Is glycyrrhizin sensitivity increased in anorexia nervosa and should licorice be avoided? Case report and review of the literature
‡9
1
|
|
919
|
|
|
‡a
intraoperativelowfieldmriintranssphenoidalpituitarysurgery
‡A
Intraoperative low field MRI in transsphenoidal pituitary surgery
‡9
1
|
|
919
|
|
|
‡a
insulinresistanceinpregnantwomenwithandwithoutpolycysticovarysyndromeandmeasuresofbodycompositioninoffspringatbirthand3yearsofage
‡A
Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and 3 years of age.
‡9
1
|
|
919
|
|
|
‡a
indirectevidencefordecreasedhypothalamicsomatostatinergictoneinanorexianervosa
‡A
Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa
‡9
1
|
|
919
|
|
|
‡a
increasedthrombingenerationinwomenwithpolycysticovarysyndromeapilotstudyontheeffectofmetforminandoralcontraceptives
‡A
Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
‡9
1
|
|
919
|
|
|
‡a
increasedriskofthyroiddiseaseindanishwomenwithpolycysticovarysyndromeacohortstudy
‡A
Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
‡9
1
|
|
919
|
|
|
‡a
incidenceofghdeficiencyanationwidestudy
‡A
Incidence of GH deficiency - a nationwide study
‡9
1
|
|
919
|
|
|
‡a
incidenceofcraniopharyngiomaindenmarkn189andestimatedworldincidenceofcraniopharyngiomainchildrenandadults
‡A
Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults
‡9
1
|
|
919
|
|
|
‡a
incidenceofcraniopharyngiomaindenmark
‡A
Incidence of craniopharyngioma in Denmark
‡9
1
|
|
919
|
|
|
‡a
invivosecretorypotentialandtheeffectofcombinationtherapywithoctreotideandcabergolineinpatientswithclinicallynonfunctioningpituitaryadenomas
‡A
In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas
‡9
1
|
|
919
|
|
|
‡a
impairedrespiratoryfunctioninwomenwithpcoscomparedwithmatchedcontrolsfromapopulationbasedstudy
‡A
Impaired Respiratory Function in Women With PCOS Compared With Matched Controls From a Population-Based Study
‡9
1
|
|
919
|
|
|
‡a
hyperandrogenismandphenotypesofpolycysticovarysyndromearenotassociatedwithdifferencesinobstetricoutcomes
‡A
Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes
‡9
1
|
|
919
|
|
|
‡a
higherbonemineraldensityincaucasianhirsutepatientsofreproductiveagepositivecorrelationoftestosteronelevelswithbonemineraldensityinhirsutism
‡A
Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism
‡9
1
|
|
919
|
|
|
‡a
hemoglobina1casatoolforthediagnosisoftype2diabetesin208premenopausalwomenwithpolycysticovarysyndrome
‡A
Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome.
‡9
1
|
|
919
|
|
|
‡a
heartvalvediseaseamongpatientswithhyperprolactinemiaanationwidepopulationbasedcohortstudy
‡A
Heart valve disease among patients with hyperprolactinemia: a nationwide population-based cohort study
‡9
1
|
|
919
|
|
|
‡a
healthanxietysymptomsindanishchildrenduringthe1lockdownperiodofthecovid19pandemicanodensechildcohortstudy
‡A
Health anxiety symptoms in Danish children during the first lockdown period of the COVID-19 pandemic: an Odense Child Cohort study
‡9
1
|
|
919
|
|
|
‡a
haircortisolintheperinatalperiodmediatesassociationsbetweenmaternaladversityanddisruptedmaternalinteractioninearlyinfancy
‡A
Hair cortisol in the perinatal period mediates associations between maternal adversity and disrupted maternal interaction in early infancy
‡9
1
|
|
919
|
|
|
‡a
graphicalinterpretationofconfidencecurvesinrankitplots
‡A
Graphical interpretation of confidence curves in rankit plots
‡9
1
|
|
919
|
|
|
‡a
giantprolactinomasinwomen
‡A
Giant prolactinomas in women
‡9
1
|
|
919
|
|
|
‡a
gestationaldiabetesmellitusdoes1sizefitallachallengetouniformworldwidediagnosticthresholds
‡A
Gestational Diabetes Mellitus: Does One Size Fit All? A Challenge to Uniform Worldwide Diagnostic Thresholds
‡9
1
|
|
919
|
|
|
‡a
geographicalvariationindxabonemineraldensityinyoungeuropeanmenandwomenresultsfromthenetworkineuropeonmaleosteoporosisnemostudy
‡A
Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study
‡9
1
|
|
919
|
|
|
‡a
geographicalvariationindxabonemineraldensityinyoungeuropeanmenandwomenresultsfromthenetworkineuropeonmaleosteoporosis
‡A
Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis
‡9
1
|
|
919
|
|
|
‡a
geneticscreeningofwnt4andwnt5bin2populationswithdeviatingbonemineraldensities
‡A
Genetic Screening of WNT4 and WNT5B in Two Populations with Deviating Bone Mineral Densities
‡9
1
|
|
919
|
|
|
‡a
geneticassociationstudyofwnt10bpolymorphismswithbmdandadiposityparametersindanishandbelgianmales
‡A
Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Belgian males
‡9
1
|
|
919
|
|
|
‡a
geneticalterationswithinthedennd1ageneinpatientswithpolycysticovarysyndromepcos
‡A
Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS)
‡9
1
|
|
919
|
|
|
‡a
geneexpressionprofilingoffastandslowgrowinggonadotrophnonfunctioningpituitaryadenomas
‡A
Gene expression profiling of fast- and slow- growing gonadotroph non-functioning pituitary adenomas
‡9
1
|
|
919
|
|
|
‡a
fractureriskisincreasedinpatientswithghdeficiencyoruntreatedprolactinomasacasecontrolstudy
‡A
Fracture risk is increased in patients with GH deficiency or untreated prolactinomas - a case-control study
‡9
1
|
|
919
|
|
|
‡a
fractureriskisdecreasedinwomenwithpolycysticovarysyndromearegisterbasedandpopulationbasedcohortstudy
‡A
Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort Study
‡9
1
|
|
919
|
|
|
‡a
fetalantigen1inhealthyadultsandpatientswithpituitarydiseaserelationtophysiologicalpathologicalandpharmacologicalghlevels
‡A
Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels
‡9
1
|
|
919
|
|
|
‡a
factorsinfluencingtheadrenocorticotropintestroleofcontemporarycortisolassaysbodycompositionandoralcontraceptiveagents
‡A
Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents
‡9
1
|
|
919
|
|
|
‡a
exposuretoperfluoroalkylsubstancesandbloodpressureinpregnancyamong1436womenfromtheodensechildcohort
‡A
Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort
‡9
1
|
|
919
|
|
|
‡a
evaluationoftheoptimumdoseofgrowthhormoneghforrestoringbonemassinadultonsetghdeficiencyresultsfrom212monthrandomizedstudies
‡A
Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies.
‡9
1
|
|
919
|
|
|
‡a
evaluationoftheoptimumdoseofgrowthhormone
‡A
Evaluation of the optimum dose of growth hormone
‡9
1
|
|
919
|
|
|
‡a
evaluationofmetabolicriskmarkersinpolycysticovarysyndromepcosadiponectinghrelinleptinandbodycompositioninhirsutepcospatientsandcontrols
‡A
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls
‡9
1
|
|
919
|
|
|
‡a
evaluationoficd10algorithmstoidentifyhypopituitarypatientsinthedanishnationalpatientregistry
‡A
Evaluation of ICD-10 algorithms to identify hypopituitary patients in the Danish National Patient Registry
‡9
1
|
|
919
|
|
|
‡a
evaluationofgrowthhormonestimulationtestsincuredacr Omega licpatients
‡A
Evaluation of growth hormone stimulation tests in cured acr Omega lic patients
‡9
1
|
|
919
|
|
|
‡a
evaluationofgrowthhormoneassaysusingratioplots
‡A
Evaluation of growth hormone assays using ratio plots
‡9
1
|
|
919
|
|
|
‡a
ethnicdifferencesinrotterdamcriteriaandmetabolicriskfactorsinamultiethnicgroupofwomenwithpcosstudiedindenmark
‡A
Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark.
‡9
1
|
|
919
|
|
|
‡a
endocrinologicalassessmenttreatmentandfollowuponpolycysticovarysyndrome
‡A
[Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome]
‡9
1
|
|
919
|
|
|
‡a
effectsofexerciseandgroupcounsellingonbodycompositionandvo2maxinoverweightwomenwithpolycysticovarysyndrome
‡A
Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.
‡9
1
|
|
919
|
|
|
‡a
effectivenessof1waytextmessagingonattendancetofollowupcervicalcancerscreeningamonghumanpapillomaviruspositivetanzanianwomenconnected2careparallelgrouprandomizedcontrolledtrial
‡A
Effectiveness of One-Way Text Messaging on Attendance to Follow-Up Cervical Cancer Screening Among Human Papillomavirus-Positive Tanzanian Women (Connected2Care): Parallel-Group Randomized Controlled Trial
‡9
1
|
|
919
|
|
|
‡a
effectoftestosteroneonmarkersofmitochondrialoxidativephosphorylationandlipidmetabolisminmuscleofagingmenwithsubnormalbioavailabletestosterone
‡A
Effect of testosterone on markers of mitochondrial oxidative phosphorylation and lipid metabolism in muscle of aging men with subnormal bioavailable testosterone.
‡9
1
|
|
919
|
|
|
‡a
effectoftestosteroneoninsulinsensitivityoxidativemetabolismandbodycompositioninagingmenwithtype2diabetesonmetforminmonotherapy
‡A
Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
‡9
1
|
|
919
|
|
|
‡a
effectofpioglitazoneonglucosemetabolismandluteinizinghormonesecretioninwomenwithpolycysticovarysyndrome
‡A
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
effectoforalcontraceptivesandormetforminonglp1secretionandreactivehypoglycaemiainpolycysticovarysyndrome
‡A
Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
effectof4weeksofoctreotidetreatmentonprolactinthyroidstimulatinghormoneandthyroidhormonesinacr Omega licpatientsadoubleblindplacebocontrolledcrossoverstudy
‡A
Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acr Omega lic patients. A double blind placebo-controlled cross-over study
‡9
1
|
|
919
|
|
|
‡a
effectof12monthtreatmentwithmetforminandororalcontraceptivesonhealthrelatedqualityoflifeinpolycysticovarysyndrome
‡A
Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
earlypregnancyvitamin500statusisassociatedwithbloodpressureinchildrenanodensechildcohortstudy
‡A
Early pregnancy vitamin D status is associated with blood pressure in children: an Odense Child Cohort study
‡9
1
|
|
919
|
|
|
‡a
doseigf1andsexdependentchangesinlipidprofileandbodycompositionduringghreplacementtherapyinadultonsetghdeficiency
‡A
Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency
‡9
1
|
|
919
|
|
|
‡a
doesmetformintreatmentduringpregnancymodifythefuturemetabolicprofileinwomenwithpcos
‡A
Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
‡9
1
|
|
919
|
|
|
‡a
discontinuationofestrogenreplacementtherapyinghtreatedhypopituitarywomenaltersandrogenstatusandigf1
‡A
Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
‡9
1
|
|
919
|
|
|
‡a
differentialdnamethylationpatternsofpolycysticovariansyndromeinwholebloodofchinesewomen
‡A
Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women
‡9
1
|
|
919
|
|
|
‡a
diagnosisofgrowthhormonedeficiency
‡A
Diagnosis of Growth Hormone Deficiency
‡9
1
|
|
919
|
|
|
‡a
diagnosisandfollowupoftype2diabetesinwomenwithpcosaroleforogtt
‡A
Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?
‡9
1
|
|
919
|
|
|
‡a
developmentofacr Omega lyinpatientswithprolactinomas
‡A
Development of acr Omega ly in patients with prolactinomas.
‡9
1
|
|
919
|
|
|
‡a
developmentandriskfactorsoftype2diabetesinanationwidepopulationofwomenwithpolycysticovarysyndrome
‡A
Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
‡9
1
|
|
919
|
|
|
‡a
dehydroepiandrosteronesupplementationinwomenwithadrenalfailureimpacton204hourghsecretionandigfrelatedparameters
‡A
Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters
‡9
1
|
|
919
|
|
|
‡a
dehydroepiandrosteronesubstitutioninfemaleadrenalfailurenoimpactonendothelialfunctionandcardiovascularparametersdespitenormalizationofandrogenstatus
‡A
Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status
‡9
1
|
|
919
|
|
|
‡a
corticotrophaggressivepituitarytumoursandcarcinomasfrequentlyharbouratrxmutations
‡A
Corticotroph aggressive pituitary tumours and carcinomas frequently harbour ATRX mutations
‡9
1
|
|
919
|
|
|
‡a
corrigendumanogenitaldistanceinchildrenbornofmotherswithpolycysticovarysyndrometheodensechildcohort
‡A
Corrigendum. Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort
‡9
1
|
|
919
|
|
|
‡a
comparisonofregionalfatmassmeasurementbywholebodydxascansandanthropometricmeasurestopredictinsulinresistanceinwomenwithpolycysticovarysyndromeandcontrols
‡A
Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
‡9
1
|
|
919
|
|
|
‡a
commongeneticvariationinthedkk1geneisassociatedwithhipaxislengthbutnotwithbonemineraldensityandboneturnovermarkersinyoungadultmenresultsfromtheodenseandrogenstudy
‡A
Common Genetic Variation in the DKK1 Gene is Associated with Hip Axis Length but not with Bone Mineral Density and Bone Turnover Markers in Young Adult Men: Results from the Odense Androgen Study
‡9
1
|
|
919
|
|
|
‡a
clubfoot
‡A
Club foot
‡9
1
|
|
919
|
|
|
‡a
clinicalmanifest10linkedrecessiveadrenoleukodystrophyinafemale
‡A
Clinical manifest x-linked recessive adrenoleukodystrophy in a female
‡9
1
|
|
919
|
|
|
‡a
chronicdiseasesinelderlymenunderreportingandunderdiagnosis
‡A
Chronic diseases in elderly men: underreporting and underdiagnosis
‡9
1
|
|
919
|
|
|
‡a
cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome
‡A
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
‡9
1
|
|
919
|
|
|
‡a
cancerincidenceinpatientswithacr Omega lyacohortstudyandmetaanalysisoftheliterature
‡A
Cancer Incidence in Patients with Acr Omega ly: A cohort study and meta-analysis of the literature.
‡9
1
|
|
919
|
|
|
‡a
brainderivedneurotrophicfactorbdnfserumbasallevelsisnotaffectedbypowertraininginmobilitylimitedolderadultsarandomizedcontrolledtrial
‡A
Brain-derived neurotrophic factor (BDNF) serum basal levels is not affected by power training in mobility-limited older adults - A randomized controlled trial
‡9
1
|
|
919
|
|
|
‡a
bonemineraldensityandvitamin500inpcosandhirsutism
‡A
Bone mineral density and vitamin D in PCOS and hirsutism
‡9
1
|
|
919
|
|
|
‡a
bodycompositionisimprovedduring12monthstreatmentwithmetforminaloneorcombinedwithoralcontraceptivescomparedwithtreatmentwithoralcontraceptivesinpolycysticovarysyndrome
‡A
Body Composition Is Improved During 12 Months' Treatment With Metformin Alone or Combined With Oral Contraceptives Compared With Treatment With Oral Contraceptives in Polycystic Ovary Syndrome
‡9
1
|
|
919
|
|
|
‡a
bloodpressureandhypertensionduringpregnancyinwomenwithpolycysticovarysyndromeodensechildcohort
‡A
Blood pressure and hypertension during pregnancy in women with polycystic ovary syndrome. Odense Child Cohort
‡9
1
|
|
919
|
|
|
‡a
bloodpressureandangiogenicmarkersinpregnancycontributorstopregnancyinducedhypertensionandoffspringcardiovascularrisk
‡A
Blood Pressure and Angiogenic Markers in Pregnancy: Contributors to Pregnancy-Induced Hypertension and Offspring Cardiovascular Risk
‡9
1
|
|
919
|
|
|
‡a
birthweightandpolycysticovarysyndromeinadultlifearegisterbasedstudyon523757danishwomenborn1973
‡A
Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973-1991.
‡9
1
|
|
919
|
|
|
‡a
awarenessofpolycysticovarysyndromeamongobstetriciangynecologistsandendocrinologistsinnortherneurope
‡A
Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe
‡9
1
|
|
919
|
|
|
‡a
associationstudyofpolymorphismsinthesostgeneregionandparametersofbonestrengthandbodycompositioninbothyoungandelderlymendatafromtheodenseandrogenstudy
‡A
Association study of polymorphisms in the SOST gene region and parameters of bone strength and body composition in both young and elderly men: data from the Odense Androgen Study
‡9
1
|
|
919
|
|
|
‡a
associationstudyofcommonvariantsinthesfrp1generegionandparametersofbonestrengthandbodycompositionin2independenthealthycaucasianmalecohorts
‡A
Association study of common variants in the sFRP1 gene region and parameters of bone strength and body composition in two independent healthy Caucasian male cohorts
‡9
1
|
|
919
|
|
|
‡a
associationofpolycysticovarysyndromesusceptibilitysinglenucleotidepolymorphismrs2479106andpcosincaucasianpatientswithpcosorhirsutismasreferraldiagnosis
‡A
Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis
‡9
1
|
|
919
|
|
|
‡a
associationofpioglitazonetreatmentwithdecreasedbonemineraldensityinobesepremenopausalpatientswithpolycysticovarysyndromearandomizedplacebocontrolledtrial
‡A
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial
‡9
1
|
|
919
|
|
|
‡a
antimullerianhormoneinpcosareviewinforminginternationalguidelines
‡A
Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines
‡9
1
|
|
919
|
|
|
‡a
anogenitaldistanceinchildrenbornofmotherswithpolycysticovarysyndrometheodensechildcohort
‡A
Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort
‡9
1
|
|
919
|
|
|
‡a
anogenitaldistanceasaphenotypicsignaturethroughinfancy
‡A
Anogenital distance as a phenotypic signature through infancy
‡9
1
|
|
919
|
|
|
‡a
updateonthepathogenesisinflammationandmetabolisminhirsutismandpolycysticovarysyndrome
‡A
An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
aldosteronesaltandpotassiumintakesaspredictorsofpregnancyoutcomeincludingpreeclampsia
‡A
Aldosterone, Salt, and Potassium Intakes as Predictors of Pregnancy Outcome, Including Preeclampsia
‡9
1
|
|
919
|
|
|
‡a
ageassociateddifferencesinprevalenceofindividualrotterdamcriteriaandmetabolicriskfactorsduringreproductiveagein446caucasianwomenwithpolycysticovarysyndrome
‡A
Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome.
‡9
1
|
|
919
|
|
|
‡a
adrenalactivityandmetabolicriskduringrandomizedescitalopramorplacebotreatmentinpcos
‡A
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS.
‡9
1
|
|
919
|
|
|
‡a
adiponectininterleukin6monocytechemoattractantprotein1andregionalfatmassduring12monthrandomizedtreatmentwithmetforminandororalcontraceptivesinpolycysticovarysyndrome
‡A
Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
adiponectinandpeakbonemassinmenacrosssectionalpopulationbasedstudy
‡A
Adiponectin and Peak Bone Mass in Men: A Cross-Sectional, Population-Based Study
‡9
1
|
|
919
|
|
|
‡a
acutepresentationofcraniopharyngiomainchildrenandadultsinadanishnationalcohort
‡A
Acute presentation of craniopharyngioma in children and adults in a Danish national cohort
‡9
1
|
|
919
|
|
|
‡a
acr Omega lynewprinciplesfortreatment
‡A
[Acr Omega ly: new principles for treatment]
‡9
1
|
|
919
|
|
|
‡a
acr Omega lyincidenceprevalencecomplicationsandlongtermprognosisanationwidecohortstudy
‡A
Acr Omega ly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
‡9
1
|
|
919
|
|
|
‡a
rarecauseofcushingssyndromeanacthsecretingphaeochromocytoma
‡A
A rare cause of Cushing's syndrome: an ACTH-secreting phaeochromocytoma
‡9
1
|
|
919
|
|
|
‡a
randomizedplacebocontrolledstudyontheeffectsofpioglitazoneoncortisolmetabolisminpolycysticovarysyndrome
‡A
A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
commonlrp4haplotypeisassociatedwithbonemineraldensityandhipgeometryinmendatafromtheodenseandrogenstudyoas
‡A
A common LRP4 haplotype is associated with bone mineral density and hip geometry in men-data from the Odense Androgen Study (OAS).
‡9
1
|
|
919
|
|
|
‡a
commongreenlandictbc1d4variantconfersmuscleinsulinresistanceandtype2diabetes
‡A
A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes
‡9
1
|
|
919
|
|
|
‡a
12monthrandomizedcrossoverstudyontheeffectsoflanreotideautogelandoctreotidelongactingrepeatableonghandigf50inpatientswithacr Omega ly
‡A
A 12-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acr Omega ly
‡9
1
|
|
919
|
|
|
‡a
wellbeingandresiliencemechanismsoftransmissionofhealthandriskinparentswithcomplexmentalhealthproblemsandtheiroffspringthewarmstudy
‡A
Wellbeing and resilience: mechanisms of transmission of health and risk in parents with complex mental health problems and their offspring--The WARM Study
‡9
1
|
|
919
|
|
|
‡a
voluntarymuscleactivationimproveswithpowertrainingandisassociatedwithchangesingaitspeedinmobilitylimitedolderadultsarandomizedcontrolledtrial
‡A
Voluntary muscle activation improves with power training and is associated with changes in gait speed in mobility-limited older adults - A randomized controlled trial
‡9
1
|
|
919
|
|
|
‡a
vitamin500statusandpthinyoungmenacrosssectionalstudyonassociationswithbonemineraldensitybodycompositionandglucosemetabolism
‡A
Vitamin D status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism
‡9
1
|
|
919
|
|
|
‡a
vitamin500levelsweresignificantlyhigherduringandafterlifestyleinterventioninpregnancyarandomizedcontrolledtrial
‡A
Vitamin D levels were significantly higher during and after lifestyle intervention in pregnancy: A randomized controlled trial
‡9
1
|
|
919
|
|
|
‡a
visceralandsubcutaneousadiposetissueassessedbymagneticresonanceimaginginrelationtocirculatingandrogenssexhormonebindingglobulinandluteinizinghormoneinyoungmen
‡A
Visceral and Subcutaneous Adipose Tissue Assessed by Magnetic Resonance Imaging in Relation to Circulating Androgens, Sex Hormone-Binding Globulin, and Luteinizing Hormone in Young Men
‡9
1
|
|
919
|
|
|
‡a
veryshorttermdehydroepiandrosteronetreatmentinfemaleadrenalfailureimpactoncarbohydratelipidandproteinmetabolism
‡A
Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism
‡9
1
|
|
943
|
|
|
‡a
199x
‡A
1991
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
DNB|1053081758
|
|
996
|
|
|
‡2
DNB|1093215240
|
|
996
|
|
|
‡2
DBC|87097969988253
|
|
996
|
|
|
‡2
LC|n 2004153772
|
|
996
|
|
|
‡2
DNB|1029302839
|
|
996
|
|
|
‡2
ISNI|0000000487319558
|
|
996
|
|
|
‡2
BIBSYS|8008003
|
|
996
|
|
|
‡2
DBC|870979137663082
|
|
996
|
|
|
‡2
BIBSYS|15011524
|
|
996
|
|
|
‡2
DBC|87097947882052
|
|
996
|
|
|
‡2
BIBSYS|90847919
|
|
996
|
|
|
‡2
DBC|87097946934806
|
|
996
|
|
|
‡2
ISNI|0000000039403668
|
|
996
|
|
|
‡2
W2Z|10050126
|
|
996
|
|
|
‡2
BIBSYS|14027640
|
|
996
|
|
|
‡2
DBC|87097991868164
|
|
996
|
|
|
‡2
DBC|87097990954490
|
|
996
|
|
|
‡2
BIBSYS|3085034
|
|
996
|
|
|
‡2
DBC|87097968062365
|
|
996
|
|
|
‡2
ISNI|0000000485216061
|
|
996
|
|
|
‡2
BIBSYS|98001628
|
|
996
|
|
|
‡2
DBC|87097991347296
|
|
996
|
|
|
‡2
BLBNB|000391626
|
|
996
|
|
|
‡2
BIBSYS|9047092
|
|
996
|
|
|
‡2
BIBSYS|99055727
|
|
996
|
|
|
‡2
CAOONL|ncf10159754
|
|
996
|
|
|
‡2
DBC|87097991362856
|
|
996
|
|
|
‡2
BIBSYS|90920839
|
|
996
|
|
|
‡2
DBC|87097968062292
|
|
996
|
|
|
‡2
DBC|87097968147506
|
|
996
|
|
|
‡2
SUDOC|181504545
|
|
996
|
|
|
‡2
DBC|87097919448088
|
|
996
|
|
|
‡2
W2Z|14002723
|
|
996
|
|
|
‡2
NUKAT|n 2021207061
|
|
996
|
|
|
‡2
LC|nr 87000402
|
|
996
|
|
|
‡2
BIBSYS|14019621
|
|
996
|
|
|
‡2
LC|no2002068863
|
|
996
|
|
|
‡2
BIBSYS|15003415
|
|
996
|
|
|
‡2
ISNI|0000000109150257
|
|
996
|
|
|
‡2
DBC|87097968586526
|
|
996
|
|
|
‡2
DNB|1171361084
|
|
996
|
|
|
‡2
DBC|87097968462770
|
|
996
|
|
|
‡2
ISNI|000000003784606X
|
|
996
|
|
|
‡2
DBC|87097946340507
|
|
996
|
|
|
‡2
DBC|87097968062314
|
|
996
|
|
|
‡2
DBC|87097968062799
|
|
996
|
|
|
‡2
ISNI|0000000073881049
|
|
996
|
|
|
‡2
DBC|87097990062379
|
|
996
|
|
|
‡2
ISNI|0000000488662892
|
|
996
|
|
|
‡2
ISNI|000000042863964X
|
|
996
|
|
|
‡2
DBC|87097968302366
|
|
996
|
|
|
‡2
BIBSYS|14002723
|
|
996
|
|
|
‡2
LC|no2007055299
|
|
996
|
|
|
‡2
DBC|87097948826369
|
|
996
|
|
|
‡2
DBC|87097990192337
|
|
996
|
|
|
‡2
DBC|87097968062985
|
|
996
|
|
|
‡2
DBC|87097968062306
|
|
996
|
|
|
‡2
DNB|137903855
|
|
996
|
|
|
‡2
SUDOC|159213177
|
|
996
|
|
|
‡2
DBC|87097939182955
|
|
996
|
|
|
‡2
BIBSYS|2095616
|
|
996
|
|
|
‡2
DBC|87097990062603
|
|
996
|
|
|
‡2
BIBSYS|90817333
|
|
996
|
|
|
‡2
W2Z|14061181
|
|
996
|
|
|
‡2
ISNI|0000000049258740
|
|
996
|
|
|
‡2
LC|no2008146463
|
|
996
|
|
|
‡2
DBC|87097992044440
|
|
996
|
|
|
‡2
BIBSYS|3004424
|
|
996
|
|
|
‡2
ISNI|0000000426245049
|
|
996
|
|
|
‡2
BIBSYS|12009604
|
|
996
|
|
|
‡2
DBC|87097968062330
|
|
996
|
|
|
‡2
NTA|239566645
|
|
996
|
|
|
‡2
BLBNB|000598055
|
|
996
|
|
|
‡2
DBC|87097969322328
|
|
996
|
|
|
‡2
DBC|87097990062352
|
|
996
|
|
|
‡2
BIBSYS|10050126
|
|
996
|
|
|
‡2
BIBSYS|11020941
|
|
996
|
|
|
‡2
PTBNP|146008
|
|
996
|
|
|
‡2
DNB|1057057118
|
|
996
|
|
|
‡2
LC|nb2008027948
|
|
996
|
|
|
‡2
BIBSYS|14061181
|
|
996
|
|
|
‡2
BLBNB|000598056
|
|
996
|
|
|
‡2
BIBSYS|14049737
|
|
996
|
|
|
‡2
LC|no2018135958
|
|
996
|
|
|
‡2
PTBNP|1752146
|
|
996
|
|
|
‡2
ISNI|000000003115293X
|
|
996
|
|
|
‡2
DBC|87097969710638
|
|
996
|
|
|
‡2
DBC|87097947882257
|
|
996
|
|
|
‡2
DBC|87097968062322
|
|
996
|
|
|
‡2
DBC|87097947139082
|
|
996
|
|
|
‡2
BIBSYS|5084474
|
|
996
|
|
|
‡2
DBC|870979134456248
|
|
996
|
|
|
‡2
DBC|87097968947499
|
|
996
|
|
|
‡2
BIBSYS|90763653
|
|
996
|
|
|
‡2
DBC|87097991007525
|
|
996
|
|
|
‡2
DBC|87097968084784
|
|
996
|
|
|
‡2
LC|n 87924885
|
|
996
|
|
|
‡2
W2Z|98001628
|
|
996
|
|
|
‡2
LC|no2007062707
|
|
996
|
|
|
‡2
BIBSYS|8045126
|
|
996
|
|
|
‡2
ISNI|0000000485813990
|
|
996
|
|
|
‡2
BIBSYS|14043661
|
|
996
|
|
|
‡2
BIBSYS|4093126
|
|
996
|
|
|
‡2
W2Z|14049737
|
|
996
|
|
|
‡2
DBC|87097919071650
|
|
996
|
|
|
‡2
PTBNP|230784
|
|
996
|
|
|
‡2
DBC|87097968062357
|
|
996
|
|
|
‡2
PTBNP|1725152
|
|
996
|
|
|
‡2
ISNI|0000000445059858
|
|
996
|
|
|
‡2
DNB|129671487
|
|
996
|
|
|
‡2
PLWABN|9814258784205606
|
|
996
|
|
|
‡2
BIBSYS|7053325
|
|
996
|
|
|
‡2
DBC|87097990062220
|
|
996
|
|
|
‡2
BIBSYS|1542227325657
|
|
996
|
|
|
‡2
DBC|87097939094398
|
|
996
|
|
|
‡2
BNF|16055068
|
|
996
|
|
|
‡2
DBC|87097968062349
|
|
996
|
|
|
‡2
DBC|870979139834976
|
|
996
|
|
|
‡2
DBC|87097969321933
|
|
996
|
|
|
‡2
DBC|87097969068049
|
|
996
|
|
|
‡2
J9U|987007329443005171
|
|
996
|
|
|
‡2
BIBSYS|12062775
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
